In this study, where we investigated the relationship between receptor change and prognosis, our data suggested that there is no relationship between receptor change and prognosis, and even if the receptors do not change, conditions associated with poor prognosis in breast cancer, such as ER and PR negativity, are less important than the pathological response in determining prognosis. The gene discussed is PGR; the disease is breast carcinoma.